Development of the Japanese version of the Ego‐Dissolution Inventory (EDI)
Neuropsychopharmacology Reports · 2024
DOI: 10.1002/npr2.12419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Keisuke Kusudo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Hallucinogens, Mental Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Aim
Psychedelics have recently gained attention as potential therapeutic agents for various psychiatric disorders. Previous research has highlighted that a diminished sense of self, commonly termed “ego‐dissolution” is a pivotal feature of the psychedelic‐induced state. While the Ego‐Dissolution Inventory (EDI) is a widely acknowledged instrument for measuring this phenomenon, no Japanese version has been available. This study aimed to develop a Japanese version of the EDI.
Methods
We adhered to the “Guidelines for Best Practices in the Translation and Cultural Modification Process for Patient‐Reported Outcomes Instruments: Document from the ISPOR Committee on Translation and Cultural Modification” during our translation approach. Two Japanese psychiatrists independently conducted initial translations, and a consolidated version was achieved via mutual agreement. This version was then back‐translated to English and assessed by the original authors for consistency. The repetitive modification process was conducted in continuous dialogues with the original authors until they accepted the concluding back‐translated version.
Results
The finalized, approved back‐translated version of the EDI is presented in the accompanying figure. In addition, the authorized Japanese version of the EDI is included in the Appendix.
Conclusions
In this study, we successfully developed the Japanese version of the EDI. This instrument will assist in assessing ego‐dissolution experiences associated with psychedelic‐assisted therapy among Japanese speakers. Additional studies are necessary to evaluate the reliability and validity of this newly translated instrument.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
- Department of Psychiatry, University of Oxford, Oxford, UK.
- University College London, Max Planck UCL Centre for Computational Psychiatry and Ageing Research, London, UK.
- University of California San Francisco Sandler Neurosciences Center, San Francisco, California, USA.
- Neurology, Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Shinichiro Nakajima, Hiroyuki Uchida
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Kusudo, K., Tani, H., Yonezawa, K., Nakajima, S., Nour, M. M., Carhart-Harris, R., & Uchida, H. (2024). Development of the Japanese version of the Ego‐Dissolution Inventory (EDI). Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12419
Vancouver
Kusudo K, Tani H, Yonezawa K, Nakajima S, Nour MM, Carhart-Harris R, et al. Development of the Japanese version of the Ego‐Dissolution Inventory (EDI). Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12419
BibTeX
@article{Kusudo2024,
author = {Kusudo, Keisuke and Tani, Hideaki and Yonezawa, Kengo and Nakajima, Shinichiro and Nour, Matthew M and Carhart-Harris, Robin and Uchida, Hiroyuki},
title = {Development of the Japanese version of the Ego‐Dissolution Inventory (EDI)},
journal = {Neuropsychopharmacology Reports},
year = {2024},
doi = {10.1002/npr2.12419}
}
EUVIMED